Sulforaphane is Synergistic with CB‐5083 and Inhibits Colony Formation of CB‐5083‐Resistant HCT116 Cells-Reference-Cited by-同舟云学术

Sulforaphane is Synergistic with CB‐5083 and Inhibits Colony Formation of CB‐5083‐Resistant HCT116 Cells

Published:2022-04-22 Issue:11 Volume:17 Page:
ISSN:1860-7179
Container-title:ChemMedChem
language:en
Short-container-title:ChemMedChem

Author:

Wang Feng¹,Li Shan¹,Rosencrans William M.¹,Cheng Kai‐Wen¹,Stott Gordon M.²,Mroczkowski Barbara³,Chou Tsui‐Fen¹⁴^ORCID

Affiliation:

1. Division of Biology and Biological Engineering California Institute of Technology Pasadena CA 91125 USA

2. NExT Program Support, Applied/Developmental Research Directorate Leidos Biomedical Research, Inc. Frederick National Laboratory for Cancer Research Frederick MD 21702 USA

3. Division of Cancer Treatment and Diagnosis National Cancer Institute Bethesda MD 20892 USA

4. Proteome Exploration Laboratory Beckman Institute California Institute of Technology Pasadena CA 91125 USA

Funder

National Institute of Neurological Disorders and Stroke

Publisher

Wiley

Subject

Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics,Molecular Medicine,Drug Discovery,Biochemistry,Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cmdc.202200030

Reference69 articles.

1. Structure and Function of p97 and Pex1/6 Type II AAA+ Complexes

2. A Mighty “Protein Extractor” of the Cell: Structure and Function of the p97/CDC48 ATPase

3. The Cdc48 machine in endoplasmic reticulum associated protein degradation

4. Proteotoxic crisis, the ubiquitin-proteasome system, and cancer therapy

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanism of allosteric inhibition of human p97/VCP ATPase and its disease mutant by triazole inhibitors;Communications Chemistry;2024-08-09

2. Exploring in vivo combinatorial chemo-immunotherapy: Addressing p97 suppression and immune reinvigoration in pancreatic cancer with tumor microenvironment-responsive nanoformulation;Biomedicine & Pharmacotherapy;2024-06

3. Harnessing Sulforaphane Potential as a Chemosensitizing Agent: A Comprehensive Review;Cancers;2024-01-05

4. An innovative nanoformulation utilizing tumor microenvironment-responsive PEG-polyglutamic coating and dynamic charge adjustment for specific targeting of ER stress inducer, microRNA, and immunoadjuvant in pancreatic cancer: In vitro investigations;International Journal of Biological Macromolecules;2024-01